Table of Content

Executive Summary



Chapter 1 – Introduction



Chapter 2 – Trends in Diagnostics dealmaking



2.1. Introduction

2.2. Diagnostics partnering over the years

2.3. Most active Diagnostics dealmakers

2.4. Diagnostics partnering by deal type

2.5. Diagnostics partnering by therapy area

2.6. Deal terms for Diagnostics partnering

2.6.1 Diagnostics partnering headline values

2.6.2 Diagnostics deal upfront payments7

2.6.3 Diagnostics deal milestone payments

2.6.4 Diagnostics royalty rates



Chapter 3 – Leading Diagnostics deals



3.1. Introduction

3.2. Top Diagnostics deals by value



Chapter 4 – Most active Diagnostics dealmakers



4.1. Introduction

4.2. Most active Diagnostics dealmakers

4.3. Most active Diagnostics partnering company profiles



Chapter 5 – Diagnostics contracts dealmaking directory



5.1. Introduction

5.2. Diagnostics contracts dealmaking directory



Chapter 6 – Diagnostics dealmaking by technology type



Chapter 7 – Partnering resource center



7.1. Online partnering

7.2. Partnering events

7.3. Further reading on dealmaking



Appendices



Appendix 1 – Diagnostics deals by company A-Z



Appendix 2 – Diagnostics deals by stage of development



Discovery

Preclinical

Phase I

Phase II

Phase III

Regulatory

Marketed

Formulation



Appendix 3 – Diagnostics deals by deal type


Asset purchase

Assignment

Bigpharma outlicensing

Co-development

Collaborative R&D

Co-market

Co-promotion

CRADA

Cross-licensing

Development

Distribution

Equity purchase

Evaluation

Grant

Joint venture

Licensing

Litigation

Manufacturing

Marketing

Material transfer

Option

Promotion

Research

Settlement

Spin out

Sub-license

Supply

Technology transfer

Termination

Warranty



Appendix 4 – Diagnostics deals by therapy area



Appendix 5 –Deal type definitions



About Wildwood Ventures



Current Partnering

Current Agreements

Recent report titles from Current Partnering



Table of figures


Figure 1: Diagnostics partnering since 2014

Figure 2: Active Diagnostics dealmaking activity since 2014

Figure 3: Diagnostics partnering by deal type since 2014

Figure 4: Diagnostics partnering by disease type since 2014

Figure 5: Diagnostics deals with a headline value

Figure 6: Diagnostics deals with an upfront value

Figure 7: Diagnostics deals with a milestone value

Figure 8: Diagnostics deals with a royalty rate value

Figure 9: Top Diagnostics deals by value since 2014

Figure 10: Most active Diagnostics dealmakers since 2014

Figure 11: Online partnering resources

Figure 12: Forthcoming partnering events